Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
3billion | RCV002293968 | SCV002587002 | pathogenic | Fabry disease | 2022-09-22 | criteria provided, single submitter | clinical testing | Different nucleotide change resulting in same amino acid change has been previously reported to be associated with GLA-related disorder (PMID: 16595074). A different missense change at the same codon (p.Gln312Arg) has been reported to be associated with GLA-related disorder (PMID: 18205205). Missense changes are a common disease-causing mechanism. The variant is not observed in the gnomAD v2.1.1 dataset. Functional studies provide strong evidence of the variant having a damaging effect on the gene or gene product (PMID: 27657681). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.74; 3Cnet: 0.99). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. |